FINVX | LIDOX | FINVX / LIDOX | |
Total Expense Ratio | 0.01 | 0.66 | 2% |
Annual Report Gross Expense Ratio | 0.01 | 0.66 | 2% |
Fund Existence | 16 years | 8 years | - |
Gain YTD | 28.356 | 22.643 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16B | 456M | 3,509% |
Annual Yield % from dividends | 3.64 | 3.06 | 119% |
Returns for 1 year | 24.06 | 21.24 | 113% |
Returns for 3 years | 78.41 | 54.55 | 144% |
Returns for 5 years | 117.03 | 74.06 | 158% |
Returns for 10 years | 93.52 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JGLO | 65.10 | 0.30 | +0.46% |
JPMorgan Global Select Equity ETF | |||
WBIG | 22.35 | 0.05 | +0.24% |
WBI BullBear Yield 3000 ETF | |||
CRSH | 4.73 | N/A | N/A |
YieldMax Short TSLA Option Income Strategy ETF | |||
IVAL | 27.94 | -0.06 | -0.21% |
Alpha Architect Intl Quant Val ETF | |||
PPH | 88.07 | -0.31 | -0.35% |
VanEck Pharmaceutical ETF |